Literature DB >> 12560094

Interplay between hnRNP A1 and a cis-acting element in the 3' UTR of CYP2A5 mRNA is central for high expression of the gene.

Tina Glisovic1, Yaacov Ben-David, Matti A Lang, Françoise Raffalli-Mathieu.   

Abstract

Our previous evidence suggests that heterogeneous nuclear ribonucleoprotein (hnRNP) A1 plays a part in the regulation of the Cyp2a5 gene by interacting with the 3' untranslated region (UTR) of the CYP2A5 mRNA. However, the exact role of this interaction is not clear. The aim of the present work was to gain further insight into the regulation process of Cyp2a5. For this purpose the 3' UTR of CYP2A5 was fused to the coding region of luciferase mRNA. Luciferase recombinants containing either the full length 3' UTR, or the 3' UTR lacking a previously described 71 nucleotide (nt) region (the hnRNP A1 primary binding site), were transiently expressed in cells expressing or lacking hnRNP A1. The expression of the luciferase recombinants was examined both at mRNA and enzyme activity levels. The results disclosed that the presence of hnRNP A1 was required for the high expression of the recombinant carrying the full length 3' UTR of CYP2A5. Deletion of the hnRNP A1 primary binding site dramatically modified the expression pattern: the mRNA levels and luciferase activities of the deletion mutant were independent from hnRNP A1. These results conclusively demonstrate that the 71 nt region in the 3' UTR of CYP2A5 mRNA can confer hnRNP A1-dependent regulation to a gene. In addition, comparison of RNA levels and luciferase activities suggested that regions flanking the hnRNP A1 binding site could regulate translation of the CYP2A5 mRNA. These results are consistent with a model in which the binding of hnRNP A1 to the 71 nt putative hairpin-loop region in the CYP2A5 mRNA 3' UTR upregulates mRNA levels possibly by protecting the mRNA from degradation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560094     DOI: 10.1016/s0014-5793(02)03893-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

Review 1.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

2.  Regulatory sequence responsible for insulin destabilization of cytochrome P450 2B1 (CYP2B1) mRNA.

Authors:  Nhu-Traï Truong; Arlette Moncion; Robert Barouki; Philippe Beaune; Isabelle de Waziers
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

3.  Ethanol induction of CYP2A5: permissive role for CYP2E1.

Authors:  Yongke Lu; Jian Zhuge; Defeng Wu; Arthur I Cederbaum
Journal:  Drug Metab Dispos       Date:  2010-11-04       Impact factor: 3.922

4.  Megaprimer-based methodology for deletion of a large fragment within a repetitive polypyrimidine-rich DNA.

Authors:  Malin Söderberg; Matti A Lang
Journal:  Mol Biotechnol       Date:  2006-01       Impact factor: 2.695

5.  Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.

Authors:  J C Mwenifumbo; C N Lessov-Schlaggar; Q Zhou; R E Krasnow; G E Swan; N L Benowitz; R F Tyndale
Journal:  Clin Pharmacol Ther       Date:  2007-05-23       Impact factor: 6.875

6.  A stress-induced tyrosine-tRNA depletion response mediates codon-based translational repression and growth suppression.

Authors:  Doowon Huh; Maria C Passarelli; Jenny Gao; Shahnoza N Dusmatova; Clara Goin; Lisa Fish; Alexandra M Pinzaru; Henrik Molina; Zhiji Ren; Elizabeth A McMillan; Hosseinali Asgharian; Hani Goodarzi; Sohail F Tavazoie
Journal:  EMBO J       Date:  2020-12-21       Impact factor: 11.598

7.  Mutations in Hnrnpa1 cause congenital heart defects.

Authors:  Zhe Yu; Paul Lf Tang; Jing Wang; Suying Bao; Joseph T Shieh; Alan Wl Leung; Zhao Zhang; Fei Gao; Sandra Yy Wong; Andy Lc Hui; Yuan Gao; Nelson Dung; Zhi-Gang Zhang; Yanhui Fan; Xueya Zhou; Yalun Zhang; Dana Sm Wong; Pak C Sham; Abid Azhar; Pui-Yan Kwok; Patrick Pl Tam; Qizhou Lian; Kathryn Se Cheah; Binbin Wang; You-Qiang Song
Journal:  JCI Insight       Date:  2018-01-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.